Published March 1994
| Version v1
Journal article
Radioiodine 131I therapy in the patients with thyroid cancer
Creators
- 1. Gunma Univ., Maebashi (Japan). School of Medicine
Description
The therapeutic value of 131I therapy of thyroid cancer with metastases was evaluated in the last 20 years. 36 patients was treated with 131I, and 18 patients had papillary and 16 patients had follicular carcinoma. 17 patients had pulmonary metastasis, and 13 patients had bone metastasis. A therapeutic dose of 131I was 3.7 GBq. The overall survival was 88% at 5 years and 65% at 10 years. Patients with pulmonary metastasis had a better prognosis than those with bone metastasis. Patients with 131I accumulation had better prognoses. (author)
Additional details
Publishing Information
- Journal Title
- Tokeibu Shuyo
- Journal Volume
- 20
- Journal Issue
- 1
- Journal Page Range
- p. 165-169.
- ISSN
- 0911-4335
- CODEN
- TOSHEG
INIS
- Country of Publication
- Japan
- Country of Input or Organization
- Japan
- INIS RN
- 25055564
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- CARCINOMAS; IODINE 131; LUNGS; METASTASES; PATIENTS; RADIATION DOSES; RADIONUCLIDE ADMINISTRATION; RADIOTHERAPY; SKELETON; SURVIVAL CURVES; THYROID; UPTAKE
- Descriptors DEC
- ANIMALS; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BODY; DAYS LIVING RADIOISOTOPES; DISEASES; ENDOCRINE GLANDS; GLANDS; INTERMEDIATE MASS NUCLEI; IODINE ISOTOPES; ISOTOPES; MAMMALS; MAN; MEDICINE; NEOPLASMS; NUCLEI; ODD-EVEN NUCLEI; ORGANS; PRIMATES; RADIOISOTOPES; RESPIRATORY SYSTEM; THERAPY; VERTEBRATES